At Issels, we specialize in advanced and highly individualized integrative treatment programs for patients suffering from cancer and immune diseases.

These complex diseases require a comprehensive approach, which we have developed throughout many years of extensive clinical experience. Using protocols that boost the body's own immune system we have had great success in improving the prognosis for many of our patients.

Natural Killer Cells, or NK Cells, could be considered the body's elite fighting force. These cellular warriors form the body's first line of defense when it is invaded by viruses or other harmful agents and when it detects aberrant cells such as cancer cells that appear as "foreign".

Living up to their name, Natural Killer Cells attack and kill tumor cells and virus-bearing cells by bombing them with protein granules. That these attacks take place at the microscopic level makes them no less devastating. Bombarded by a fuselage of protein "bombs," tumor cells disintegrate and die in a process known as apoptosis, or programmed cell death.

Natural Killer Cells evolve from lymphoid stem cells which originate in your bone marrow, as do all immune system cells. Lymphoid stem cells produce the lymphocytes that identify foreign invading organisms and "foreign" appearing cancer cells, so they can be targeted by the immune system. Administration of Activated Autologous Lymphocytes may be included in individualized integrated immunotherapy programs to enhance immune system response and promote the activation of NK Cells.

We invite you to contact one of our patient care specialists today to chat about how the Issels immunobiologic core treatment program may be the right choice for your health needs. We invite you to phone 1-888-447-7357 or visit us online at www.Issels.com.

Issels has been a leader in individualized immunotherapy for over 60 years. Our extensive experience in integrating vaccines into a personalized non-toxic cancer treatment has achieved complete long-term remission of
advanced and standard-therapy resistant cancers.